The Vaccine Management Act was implemented on 1 December

June 29, the 11th session of the Standing Committee of the 13th National People's Congress passed the Vaccine Management Law, which will come into effect on December 1, 2019. At a special press conference on vaccine management law held in Beijing by the General Office of the Standing Committee of the National People's Congress, Jia Hong, director of the State Drug Administration, said that compared with general drugs, vaccines have their particularity, mainly reflected in: First, vaccines involve public safety and national security, vaccine management law clearly stipulates that vaccines are national strategic, public welfare products;He said that China has 45 vaccine manufacturers, can produce more than 60 kinds of vaccines, annual production capacity of more than 1 billion doses. China has twice passed the Evaluation of the World Health Organization's Vaccine Management System in 2011 and 2014, which is a full recognition of the World Health Organization's vaccine industry and regulatory capacity in China.
Yuan Lin, director of the drug regulatory department of the State Drug Administration, said the vaccine control law has many new initiatives to strengthen vaccine regulation. The first is to fully implement the responsibilities of all parties, the second is to focus on strengthening the regulatory measures in all links, the third is to further emphasize and clarify the need to strengthen the disclosure of information, and the fourth is to further strengthen the supervision of vaccines. Now there are only 800 national-level drug inspectors, the vaccine management law clearly proposed that at the central and provincial levels, the establishment of professional, professional inspectors, strengthen the construction of inspectors and capacity-building, further strengthen the supervision, inspection and full life cycle of the vaccine supervision, to ensure the quality and safety of vaccines.Regarding the question about the implementation of catalog management in the scope of compensation for vaccination abnormal reactions, Cui Gang, deputy inspector of the Disease Prevention and Control Bureau of the National Health And Wellness Commission, said that China has established a relatively perfect surveillance system for vaccination abnormal reactions, hoping to come up with a catalogue as soon as possible for abnormal response identification and investigation and diagnosis services, so that people can be more assured. (Health Journal)